↓ Skip to main content

Principles of Anticancer Drug Development

Overview of attention for book
Cover of 'Principles of Anticancer Drug Development'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Basic Biostatistics for the Clinical Trialist
  3. Altmetric Badge
    Chapter 2 Fundamental Concepts in Clinical Pharmacology
  4. Altmetric Badge
    Chapter 3 Bioanalytical Methods in Clinical Drug Development
  5. Altmetric Badge
    Chapter 4 Preclinical Models for Anticancer Drug Development
  6. Altmetric Badge
    Chapter 5 Phase I Clinical Trials with Anticancer Agents
  7. Altmetric Badge
    Chapter 6 Phase II Trials with Anticancer Agents
  8. Altmetric Badge
    Chapter 7 Phase III Clinical Trials with Anticancer Agents
  9. Altmetric Badge
    Chapter 8 Pharmacokinetic Studies in Early Anticancer Drug Development
  10. Altmetric Badge
    Chapter 9 Pharmacodynamic Studies in Early Phase Drug Development
  11. Altmetric Badge
    Chapter 10 Prediction of Antitumor Response
  12. Altmetric Badge
    Chapter 11 Imaging Studies in Anticancer Drug Development
  13. Altmetric Badge
    Chapter 12 Role of the US Food and Drug Administration in Cancer Drug Development
  14. Altmetric Badge
    Chapter 13 Early Clinical Trials with Cytotoxic Agents
  15. Altmetric Badge
    Chapter 14 Challenges and Successes in Developing Effective Anti-angiogenic Agents
  16. Altmetric Badge
    Chapter 15 Targeted Therapeutics in Cancer Treatment
  17. Altmetric Badge
    Chapter 16 Cancer Chemoprevention
  18. Altmetric Badge
    Chapter 17 Combined Modality Therapy in Cancer Management
  19. Altmetric Badge
    Chapter 18 Cancer Vaccines
  20. Altmetric Badge
    Chapter 19 Optimising the Development of Antibodies as Treatment for Cancer
  21. Altmetric Badge
    Chapter 20 Oligonucleotide Therapeutics
  22. Altmetric Badge
    Chapter 21 Anticancer Drug Development in Pediatric Patients
  23. Altmetric Badge
    Chapter 22 Clinical Trials in Special Populations
  24. Altmetric Badge
    Chapter 23 NCI-Sponsored Clinical Trials
Attention for Chapter 1: Basic Biostatistics for the Clinical Trialist
Altmetric Badge

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
14 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Basic Biostatistics for the Clinical Trialist
Chapter number 1
Book title
Principles of Anticancer Drug Development
Published by
Springer, New York, NY, January 2011
DOI 10.1007/978-1-4419-7358-0_1
Book ISBNs
978-1-4419-7357-3, 978-1-4419-7358-0
Authors

Elizabeth G. Hill, Elizabeth Garrett-Mayer

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 14 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 7%
Unknown 13 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 36%
Student > Master 3 21%
Professor > Associate Professor 2 14%
Lecturer > Senior Lecturer 2 14%
Student > Ph. D. Student 1 7%
Other 0 0%
Unknown 1 7%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 4 29%
Medicine and Dentistry 3 21%
Biochemistry, Genetics and Molecular Biology 2 14%
Mathematics 1 7%
Veterinary Science and Veterinary Medicine 1 7%
Other 2 14%
Unknown 1 7%